Total Return chart Alzinova AB

Stocks

Market Closed - Nasdaq Stockholm 20:00:00 13/08/2026 +04			5-day change	1st Jan Change
1.002 ^SEK	+8.68%		-7.22%	+20.87%

06-24	Alzinova AB and Fujirebio Enter Letter of Intent for Potential Commercialization of Blood-Based Alzheimer?S Diagnostic Test	CI
06-24	Alzinova Inks Nonbinding Deal with Fujirebio for Potential Alzheimer's Blood-based Diagnostic Test	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.